EXAS - EXACT SCIENCES CORP

QQQ $ 459.70 $ 0.56 (0.12 %)

DIA $ 407.95 $ -2.47 (-0.6 %)

SPY $ 548.56 $ -2.39 (-0.43 %)

TLT $ 99.56 $ 0.55 (0.56 %)

GLD $ 232.35 $ 1.92 (0.83 %)

Previous Close

$ 60.91

Open

$ 57.56

Bid

$ 60.48 x 100

Ask

$ 65.00 x 1,966

Day's Range

$ 57.44 - $ 62.17

52 Week Range

$ 40.62 - $ 85.15

Volume

1,802,455

Average Volume

Market Cap

10.56B

Beta (5Y Monthly)

$ 1.20

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-21-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-01-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	02-21-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	04-26-2022	03-31-2022	10-Q
11	02-22-2022	12-31-2021	10-K
12	11-02-2021	09-30-2021	10-Q
13	07-28-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	02-16-2021	12-31-2020	10-K
16	10-27-2020	09-30-2020	10-Q
17	07-31-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-21-2020	12-31-2019	10-K
20	10-30-2019	09-30-2019	10-Q
21	07-30-2019	06-30-2019	10-Q
22	04-30-2019	03-31-2019	10-Q
23	02-21-2019	12-31-2018	10-K
24	10-30-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	04-26-2018	03-31-2018	10-Q
27	02-22-2018	12-31-2017	10-K
28	10-30-2017	09-30-2017	10-Q
29	07-25-2017	06-30-2017	10-Q
30	04-27-2017	03-31-2017	10-Q
31	02-21-2017	12-31-2016	10-K
32	10-26-2016	09-30-2016	10-Q
33	07-26-2016	06-30-2016	10-Q
34	05-03-2016	03-31-2016	10-Q
35	02-24-2016	12-31-2015	10-K
36	10-30-2015	09-30-2015	10-Q
37	07-31-2015	06-30-2015	10-Q
38	05-04-2015	03-31-2015	10-Q
39	02-27-2015	12-31-2014	10-K
40	10-31-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Initiates Coverage On Exact Sc...
08/27/2024 22:11:05

Wells Fargo analyst Brandon Couillard initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Overweight rating and announ...

Exact Sciences Launches Multi-Cancer Early...
08/20/2024 11:07:56

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the first...

Exact Sciences Shared New Modeling Data De...
08/15/2024 11:10:39

9-health-care-stocks-whale-activity-in-todays-session

9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio

DoorDash And Exact Sciences Are Among Top ...
08/04/2024 14:32:50

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

Crude Oil Moves Lower; Moderna Shares Plunge
08/01/2024 18:34:37

exact-sciences-analysts-slash-their-forecasts-after-q2-results

Exact Sciences Analysts Slash Their Foreca...
08/01/2024 18:14:37

Benchmark Maintains Buy on Exact Sciences,...
08/01/2024 18:04:23

Benchmark analyst Bruce Jackson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $91 to $67.

dow-dips-over-500-points-ism-manufacturing-pmi-falls-in-july

Dow Dips Over 500 Points; ISM Manufacturin...
08/01/2024 16:06:46

Air Products Posts Upbeat Earnings, Joins ...
08/01/2024 15:42:35

Stifel Maintains Buy on Exact Sciences, Lo...
08/01/2024 14:34:33

Stifel analyst Daniel Arias maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 to $82.

exact-sciences-stock-climbs-after-strong-q2-results

Exact Sciences Stock Climbs After Strong Q...
07/31/2024 21:45:04

Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's ...

Exact Sciences Maintains Full-year 2024 Re...
07/31/2024 20:27:07

Raises full-year adjusted EBITDA guidance midpoint by $8M.

TwinStrand Biosciences Enters Agreement Wi...
07/31/2024 20:14:37

The license is related to TwinStrand Duplex Sequencing® error-correction technology, which increases the accuracy of next-gener...

Exact Sciences Q2 2024 GAAP EPS $(0.09) Be...
07/31/2024 20:06:49

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.32...

fda-greenlights-guardant-healths-shield-blood-test-analyst-cautious-on-adoption

FDA Greenlights Guardant Health's Shield B...
07/29/2024 17:21:32

FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-appro...

Peeling Back The Layers: Exploring Exact S...
07/17/2024 17:00:48

Goldman Sachs Maintains Buy on Exact Scien...
07/17/2024 16:02:22

Goldman Sachs analyst Matthew Sykes maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $88 t...

Evercore ISI Group Maintains Outperform on...
07/02/2024 15:22:14

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...

Geneoscopy Files Lawsuit Against Exact Sci...
07/01/2024 12:21:09